• Bio-Imaging Technologies (Newtown, Pennsylvania), a provider of clinical data service, acquired privately held Phoenix Data Systems (King of Prussia, Pennsylvania), a provider of electronic data capture (EDC) services and interoperable eClinical data solutions to the pharma, biotech and medical device industries. Bio-Imaging, which assists clients in the design and management of the medical imaging component of clinical trials, said the acquisition is a cash/stock transaction valued at $24 million: $7 million in cash and 2,287,582 shares of Bio-Imaging stock valued at $17 million. Phoenix delivers EDC series through a combination of electronic data capture, interactive voice response, reporting and data management, designed to streamline the clinical research process by providing early visibility to clinical research data. Phoenix will retain its name and continue to be managed by its president, Dr. William Claypool.

• CTS (Elkhart, Indiana) acquired Orion Manufacturing (San Jose, California) for about $10 million in cash, and potential earnouts of up to $1.75 million in cash, based on financial milestones in 2008/2009. Orion provides electronics manufacturing services to the defense and aerospace, industrial and medical markets, with 2007 sales of about $27 million. CTS is a provider of electronics manufacturing services to OEMs in a variety of medical markets. It said it plans to combine the Orion operation with its operation in Santa Clara, California.

• Diomed Holdings (Andover, Massachusetts) said it has filed for Chapter 11 in the Bankruptcy Court for the District of Massachusetts, Western Division, indicating that it will sell certain assets to Biolitec (Jena, Germany), a manufacturer of medical lasers and optical fibers for $6 million to $7 million. This will enable Biolitec to continue to operate Diomed's business in the U.S. With court approval, Diomed will operate as a debtor-in-possession as it pursues the sale to Biolitec and sale of other assets to third parties. The company said it expects to complete the sale to Biolitec in 60 to 90 days and sale of the other assets "in due course."

• HealthTronics (Austin, Texas), a provider of urology services and products, said it has agreed to acquire Advanced Medical Partners (AMP; Columbia, South Carolina). Financial terms were not disclosed. AMP is a provider of urological cryosurgery services in the U.S., with an interest in 30 entities, generating revenue of more than $24 million in 2007. Bob Yonke, an AMP founder and CEO, said the combination "will allow our physician partners to benefit from HealthTronics' scale and exclusive urological technologies ... [and] we will have the ability to utilize the resources of HealthTronics to continue our growth and development of existing and new physician partnerships."

• Hillenbrand Industries (Batesville, Indiana) approved the previously disclosed spin-off of Batesville Holdings to be the post-separation holding company for the Batesville Casket funeral business. Hillenbrand's shareholders approved the change of Hillenbrand's name to Hill-Rom at separation. Batesville Holdings will change its name to Hillenbrand. The new Hill-Rom Holdings will trade on the NYSE under the symbol HRC. Hillenbrand will trade on the NYSE under the symbol HI.

• Immucor (Norcross, Georgia) agreed to acquire BioArray Solutions (Warren, New Jersey) for about $117 million in cash. Immucor provides automated instrument-reagent systems to the blood transfusion industry; BioArray develops molecularod transfusion diagnostic systems for antigen determination for blood transfusion donors and recipients by DNA analysis using its BeadChip system. BioArray will continue to be based in Warren, New Jersey, operating under the name BioArray Solutions. Equity holders of BioArray intend to form a new compan to commercialize BioArray technologies in fields outside of blood transfusion and transplantation. Immucor gains 19% ownership in the new company.

• Misonix (Farmingdale, New York), a developer of minimally invasive ultrasonic technology for the treatment of cancer and other chronic health conditions will sell its equity position in Focus Surgery (Indianapolis). Focus develops High Intensity Fo-cused Ultrasound (HIFU) technology and the Sonablate 500 (SB500) for the HIFU treatment of prostate cancer. Misonix retains the right to distribute the SB500 in the EU and Eastern Europe and the rights to use Focus's HIFU technology to develop devices to treat cancer in the kidney, liver and breast.

• Orthopedics firm Orthofix International (Huntersville, North Carolina) said it sold all of the intellectual property, business assets and distribution rights related to the Pain Care line of ambulatory infusion pumps, previously made by its sports medicine subsidiary, Breg (Vista, California). LMA International (Singapore) will pay about $5.9 million in cash upon close, and an another $1 million based on attaining certain revenue-generation objectives during the first six-months after the closing. Breg will continue to manufacture the Pain Care products for LMA during a transition period of up to 18 months.